Cellectar Biosciences Stock (NASDAQ: CLRB) stock price, news, charts, stock research, profile.
You can purchase shares of Cellectar Biosciences (NASDAQ:CLRB) through any online brokerage.
Other companies in Cellectar Biosciences’s space includes: Renovaro (NASDAQ:RENB), Serina Therapeutics (AMEX:SER), Connect Biopharma Hldgs (NASDAQ:CNTB), Gritstone Bio (NASDAQ:GRTS) and OS Therapies (AMEX:OSTX).
Cellectar Biosciences has a consensus price target of $14.67.
The stock price for Cellectar Biosciences (NASDAQ: CLRB) is $2 last updated September 24, 2024 at 4:42 PM EDT.
There are no upcoming dividends for Cellectar Biosciences.
Cellectar Biosciences’s Q3 earnings are confirmed for Thursday, October 31, 2024.
There is no upcoming split for Cellectar Biosciences.
Cellectar Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.